Next report date
Report period
Q1 2024
EPS estimate
−0.92USD
Revenue estimate
11.92 MUSD
−106.79 MUSD
153.73 MUSD
73.77 M
Om Sutro Biopharma, Inc.
Sektor
Bransch
VD
William J. Newell
Webbplats
Huvudkvarter
South San Francisco
Employees (FY)
302
Grundat
2003
FIGI
BBG000R4V3P3
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
